Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net loss	$ (13,469,271)	$ (8,532,792)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation	3,334	3,613
Common stock issued for professional fees	141,020	1,117,782
Loss on settlement of debt	142,551
Gain on deconsolidation of subsidiary	(241,365)
Changes in assets and liabilities:
Accounts receivables, net	192,121	(258,820)
Holdback receivables	(1,306,069)	(2,180,270)
Inventories	868,324	172,813
Due from related party	(2,514)
Other assets	21,783	(75,811)
Accounts payable and accrued expenses	5,463,942	1,967,850
Refunds payable	(179,257)	165,550
Royalty payable	398,149	704,203
Chargebacks payable	263,352	153,969
Net cash used in operating activities	(7,703,900)	(6,761,913)
Cash flows from investing activities:
Purchases of equipment	(1,604)
Proceeds from disposition of asset		28,397
Net cash provided by (used in) financing activities	(1,604)	28,397
Cash flows from financing activities:
Proceeds from convertible debt	500,000	3,585,000
Proceeds from borrowings from stockholder	1,488,817	3,672,028
Proceeds from borrowings from related parties		317,610
Net cash provided by financing activities	1,988,817	7,574,638
Net increase (decrease) in cash	(5,716,687)	841,122
Deconsolidation - Cash	(41,107)
Cash – beginning of period	5,843,323	78,856
Cash – end of period	85,529	919,978
Supplemental disclosures of cash flow information
Interest	2,334	1,125
Income taxes
Non-cash investing and financing activities:
Due to Emblaze One, Inc. by Limitless X	1,167,011
Due from Vybe Labs, Inc. by Limitless X	$ (1,356,750)